Literature DB >> 15577319

Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients.

Bianca Costa Soares de Sá1, Gisele G Rezze, Ana Paula Scramim, Gilles Landman, Rogério I Neves.   

Abstract

This study was performed to analyse the behaviour, risk factors, prognosis and evolution of cutaneous melanoma in childhood and adolescence treated in a single institution. A retrospective study was performed between 1980 and 2000 of patients aged 18 years or younger followed at the Hospital do Cancer de Sao Paulo, Brazil. Data included demographic status, risk factors, clinical and histopathological characteristics of the primary and metastatic lesions, stage and follow-up. Seventeen female (53.1%) and 15 male (46.9%) patients were studied. Twelve patients (37.5%) were aged 12 years or younger. The trunk was the most common location (14 patients; 43.8%). Five patients (15.6%) had giant congenital melanocytic naevus, three (9.4%) had xeroderma pigmentosum and one (3%) had dysplastic melanocytic naevus. Nodular melanoma was the most frequent histological type and 43.8% had a thickness of more than 4 mm. Five of the 32 patients (15.6%) were lost to follow-up and 15 (46.9%) were alive at the last year's follow-up, 11 (34.4%) without disease and four (12.5%) with active disease. The 5-year overall survival was 64.34%. An overall survival of 11.71% was found in patients with visceral metastasis with or without cutaneous and/or lymph node involvement, whereas the corresponding value was 90.48% (P value=0.0002) in patients with only cutaneous and/or lymph node metastasis. Cutaneous melanomas are uncommon in the young and are seldom diagnosed in the early stages, perhaps due to a reluctance to accept this diagnosis in this age group. Prevention and early stage diagnosis depend upon the recognition that this disease is present in the young.

Entities:  

Mesh:

Year:  2004        PMID: 15577319     DOI: 10.1097/00008390-200412000-00008

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

Review 1.  Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.

Authors:  Fernando Antônio Gomes de Andrade; Claudio Eduardo de Oliveira Cavalcanti; Felipe Contoli Isoldi; Lydia Masako Ferreira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

2.  Retrospective analysis of melanocytic lesions in children at the National Cancer Institute-RJ.

Authors:  Lislaine Bomm; Ricardo Vianna de Carvalho; Fernanda Ferreira da Silva Lima; Lidicie Natalia Braga de Oliveira; Fernanda Tolstoy; Dolival Lobão
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

3.  [Malignant melanoma in children and adolescents].

Authors:  A Rütten
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

4.  Neonatal congenital malignant melanoma with lymph node metastasis.

Authors:  Shannon Tierney McElearney; Lynn T Dengel; Ann Byron Robertson Vaughters; James W Patterson; Eugene D McGahren; Craig L Slingluff
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

5.  Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.

Authors:  Valcinir Bedin; Randall L Adam; Bianca Cs de Sá; Gilles Landman; Konradin Metze
Journal:  BMC Cancer       Date:  2010-06-05       Impact factor: 4.430

6.  Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.

Authors:  Karina Miranda Santiago; Amanda França de Nóbrega; Rafael Malagoli Rocha; Silvia Regina Rogatto; Maria Isabel Achatz
Journal:  Int J Mol Sci       Date:  2015-04-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.